Quick Answer
Altamira Therapeutics Ltd. reported Stockholders Equity of $16.77 million for fiscal year 2020.
Altamira Therapeutics Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2020 | $16.77M | +177.8% |
| 2019 | $6.04M | — |
- Altamira Therapeutics Ltd. showed an increase of +177.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2020 period, Altamira Therapeutics Ltd.’s stockholders equity has grown by 177.8% (from $6.04 million to $16.77 million).
- The most recent figure is from Altamira Therapeutics Ltd.’s fiscal year 2020 report (Form 20-F), filed with the SEC on March 31, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: